Brain effects of leptin: What intracellular mechanism? Kamal Rahmouni Invited Commentary Pages: 427 - 429
Chronic inflammatory demyelinating polyneuropathy and diabetes Andrew J. M. Boulton Clinical Trials Report Pages: 437 - 438
New treatments for diabetic neuropathy: Pathogenetically oriented treatment Angelika BierhausPer M. HumpertPeter P. Nawroth OriginalPaper Pages: 452 - 458
New treatments for diabetic neuropathy: Symptomatic treatments Singhan T. M. KrishnanGerry Rayman OriginalPaper Pages: 459 - 467
New treatments for diabetic neuropathic foot ulceration: Views from a wound healing unit Dean T. WilliamsKeith G. Harding OriginalPaper Pages: 468 - 474
The International Consensus and practical guidelines on the management and prevention of the diabetic foot Nicolaas C. SchaperJan ApelqvistKarel Bakker OriginalPaper Pages: 475 - 479
Growth factors and the development of diabetic nephropathy Gunter Wolf OriginalPaper Pages: 485 - 490
The role of renal proximal tubular cells in diabetic nephropathy Aled O. Phillips OriginalPaper Pages: 491 - 496
Proteinuria in diabetic nephropathy: Treatment and evolution Ruth C. CampbellPiero RuggenentiGiuseppe Remuzzi OriginalPaper Pages: 497 - 504